2025
Berger A, Sarniguet J, Hugon G, Cubedo N, Morel S, Chabi B, Vernus B, Bonnieu A, Brun A, Matecki S, Rossel M*, Carnac G*. Advances in identifying functional groups in carnosol analogs to assess their efficacy in skeletal muscle function. Biomed Pharmacother. September 2025;190:118397. doi: 10.1016/j.biopha.2025.118397..
Cagalinec M, Mohd A, Borecka S, Bultynck G, Choubey V, Yanovsky-Dagan S, Ezer S, Gasperikova D, Harel T, Jurkovicova D, Kaasik A, Liévens JC, Maurice T, Peviani M, Richard EM, Skoda J, Skopkova M, Tarot P, Van Gorp R, Zvejniece L, Delprat B. Improving the integrity of mitochondria-associated endoplasmic reticulum membranes as a converging therapeutic strategy for rare neurodegenerative diseases and cancer. Biochim Biophys Acta Mol Cell Res. June 2025;1872(5):119954. doi: 10.1016/j.bbamcr.2025.119954.
Canet G, Zussy C, Vitalis M, Morin F, Chevallier N, Hunt H, Claeysen S, Blaquière M, Marchi N, Planel E, Meijer OC, Desrumaux C, Givalois L . Advancing Alzheimer’s disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models. Br J Pharmacol. 2025. doi: 10.1111/bph.17457.
Carles A, Freyssin A, Guehairia S, Reguero T, Vignes M, Hirbec H, Rubinstenn G, Maurice T. Neuroprotection through chronic administration of fluoroethylnormemantine (FENM) in mouse models of Alzheimer’s disease. Alzheimers Res Ther. 2025. 17(1):7.
De Boose P, Ribas FO, Bell D, Bouga M, De Borre E, Fröhlich J, Hatjina F, Huss A, Kalapouti A, Katsamenis OL, Blackwell L, Georgiadou P, Mohiud-Din A, Alshamrani E, Lasbleiz C, Stavrinides M, Thanou Z, Tsagkarakis A, Varnava A, Zahner M, Wijnen H, Thielens A. Behavior and reproduction of Drosophila melanogaster exposed to 3.6 GHz radio-frequency electromagnetic fields. PLoS One. Dec. 1, 2025;20(12):e0336228. doi: 10.1371/journal.pone.0336228.
Ferrero E, Vaz FM, Cheillan D, Brusco A, Marelli C. The ELOVL proteins: Very- and ultra-long-chain fatty acids at the crossroads between metabolic and neurodegenerative disorders. Mol Genet Metab. 2025 144(3):109050.
Forner-Piquer I, Klement W, Gangarossa G, Zub E, de Bock F, Blaquiere M, Maurice T, Audinat E, Faucherre A, Lasserre F, Ellero-Simatos S, Gamet-Payrastre L, Jopling C, Marchi N. Corrigendum to “Varying modalities of perinatal exposure to a pesticide cocktail elicit neurological adaptations in mice and zebrafish” [Environ. Pollut. 278 (2021) 116755]. Environ Pollut. Feb 1, 2025;366:125432. doi: 10.1016/j.envpol.2024.125432. Epub Dec 5, 2024. Erratum for: Environ Pollut. Jun 1, 2021;278:116755. doi: 10.1016/j.envpol.2021.
Gazard CM, Douich N, Néel E, Villette P, Perrin FE, Gerber YN. Behavioral Settings Are Crucial for Assessing Sensorimotor, Anxiety, and Social Changes in Aging and Spinal Cord Injury. Brain Behav. July 2025;15(7):e70686. doi: 10.1002/brb3.70686.
He F, Hofmann J, Poeta E, Monti B, Crouzier L, Maurice T, Decker M. Vitamin K-Trolox synergism in a hybrid neuroprotectant with potent anti-ferroptosis/oxytosis activity, reduced toxicity, and in vivo efficacy in a mouse model of Alzheimer’s disease. Eur J Med Chem. Dec 5, 2025;299:118068. doi: 10.1016/j.ejmech.2025.118068..
Larralde C, Pradeau-Phélut L, Alvès S, Percevault F, Primig M, Huclier-Markai S, Garnier C. Natural L-Hexapeptides with Therapeutic Potential for Alzheimer’s Disease and Tauopathies. ACS Omega. Oct. 9, 2025;10(41):48531-48543. doi: 10.1021/acsomega.5c06191.
Le Friec J, Mourier H, Couly S, Cubedo N, Dubois K, Meunier J, Delprat B, De Zordo-Banliat A, Ayad T, Virieux D, Su TP, Lasbleiz C, Maurice T, Liévens JC. Positive modulation of the sigma-1 receptor: a new strategy to slow disease progression in amyotrophic lateral sclerosis. Transl Neurodegener. Dec 15, 2025;14(1):68. doi: 10.1186/s40035-025-00527-z.
Manesco C, Cloitre T, Martin M, Gerber YN, Perrin FE, Saavedra-Villanueva O, Gergely C. Analysis of Undergrowth Collagen Fibers Using the Fingerprint Enhancement Method. Biol Cell. Apr 2025;117(4):e70001. doi: 10.1111/boc.70001.
Maurice T. Prevention of memory impairment and hippocampal injury with blarcamesine in an Alzheimer’s disease model. Neurosci Lett. Oct. 14, 2025;865:138349. doi: 10.1016/j.neulet.2025.138349.
Micheau J, Catheline G, Barse E, Hiba B, Marcilhac A, Allard M, Platt B, Riedel G.PLB2Tau mice are impaired in novel and temporal object recognition and show corresponding features on brain MRI. Brain Res Bull. 2025. 220:111161.
Ng S, Derraz I, Marnat G, Jecko V, Papaxanthos J, Bellanger G, Cognard C, Sol JC, Le Van T, Berhouma M, Thouant P, Jacquesson T, Eker O, El Fertit H, Liebskind DS, Molinari N, Lonjon N, Costalat V; OTEMACS study group. Embolization of the middle meningeal artery for chronic subdural hematoma: The OTEMACS multicenter, randomized, clinical trial protocol. Interv Neuroradiol. July 7, 2025:15910199251356098. doi: 10.1177/15910199251356098.
Otaegui L, Urgin T, Zaiter T, Zussy C, Vitalis M, Pellequer Y, Acar N, Vigor C, Galano JM, Durand T, Givalois L, Béduneau A, Desrumaux C. Nose-to-brain delivery of DHA-loaded nanoemulsions: A promising approach against Alzheimer’s disease. Int J Pharm. 2025. 7;670:125125.
Poulen G, Douich N, Gazard CM, Mestre-Francés N, Cardoso M, Bauchet L, Vachiery-Lahaye F, Lonjon N, Gerber YN, Perrin FE. Sex and age differences in glia and myelin in nonhuman primate and human spinal cords: implications for pathology. Cell Death Discov. April 2, 2025;11(1):129.
Poulen G, Gélisse P, Crespel A, Chan-Seng E, Moser PO, Coubes P. Does deep brain stimulation of the anterior thalamic nucleus represent the future of Lennox-Gastaut syndrome? J Neurol. April 3, 2025;272(4):312. doi: 10.1007/s00415-025-13053-9.
Pradeau-Phélut L, Alvès S, Le Tareau L, Larralde C, Bernard E, Schirmer C, Lai-Kee-Him J, Lepvrier E, Bron P, Delamarche C, Garnier C. An Efficient Biochemical Method for Characterizing and Classifying Related Amyloidogenic Peptides. Anal Chem. 2025. 97(2):1078-1086.
Quilgars C, Boué-Grabot E, de Deurwaerdère P, Cazalets JR, Perrin FE, Bertrand SS. Brief early-life motor training induces behavioral changes and alters neuromuscular development in mice. PLoS Biol. April 21, 2025;23(4):e3003153. doi: 10.1371/journal.pbio.3003153.
Sałaciak K, Lustyk K, Jagielska A, Szafarz M, Inteiro-Oliveira S, Diógenes MJ, Xapelli S, Schnur P, Morton L, Moran E, Ferreira J, Sakata S, Crouzier L, Meunier J, Delprat B, Maurice T, Pytka K. The multimodal Sigma-1-targeting compound HBK-15 reverses memory deficits and restores hippocampal plasticity in the presence of NMDA hypofunction. Neurotherapeutics. Nov 3, 2025:e00774. doi: 10.1016/j.neurot.2025.e00774.
Sanrey E, Grasso M, Brethome M, Chan-Seng E, Gil V, Coubes P, Poulen G. Quality of Life after Deep Brain Stimulation: A Comparative Study of Primary versus Secondary Dystonia. Stereotact Funct Neurosurg. 2025;103(3):206-211. doi: 10.1159/000545755.
Strachan EL, Dillon ET, Sullivan M, Glennon JC, Peyrel A, Sarniguet J, Dubois K, Delprat B, Kennedy BN, O’Sullivan NC. Novel in vivo models of autosomal optic atrophy reveal conserved pathological changes in neuronal mitochondrial structure and function. FASEB J. April 15, 2025;39(7):e70497. doi: 10.1096/fj.202403271R.
Tchan M, Lehman A, van Dussen L, Langendonk JG, Janssen MCH, Langeveld M, Murphy E, Ryder B, Glamuzina E, Merkel M, Sechi A, Arnoux JB, Mochel F, Alkemade G, Maillot F, Kaphan E, Mazodier K, Thomas Q, Leguy-Seguin V, Marelli C. The Frequencies of Different Inborn Errors of Metabolism in Adult Metabolic Centers: 10 Years Later, Another Report From the SSIEM Adult Metabolic Physicians Group. J Inherit Metab Dis. 2025, 48(2):e70005.
Theuriet J, Paulet L, Acket B, Ory-Magne F, Belbachir H, Chanson JB, Bouhour F, Laurencin C, Froment Tilikete C, Lardeux P, Clement G, Hocquel A, Renaud M, Bonnet C, Marelli C, Weber S, Comet C, Azulay JP, Fluchère F, Coarelli G, Heinzmann A, Ewenczyk C, Verny C, Guillet-Pichon V, Guyant-Marechal L, Desjardins C, Riou A, Degos B, Mercier S, Goizet C, Degoutin M, Angelini C, Laurens B, Degardin A, Carrière N, Le Guyader G, Schneider V, Dupont G, Thomas Q, Merindol M, Besse-Pinot E, Méneret A, Roze E, Durr A, Thobois S, Anheim M, Wirth T, Pegat A. Neuropathy in GAA-FGF14 Late-Onset Cerebellar Ataxia (SCA27B): Prevalence and Characteristics. Eur J Neurol. July 2025;32(7):e70247. doi: 10.1111/ene.70247.
Zhang X, Robine JM, Gondo Y. Changes in physical functioning among centenarians and the impact of COVID-19: A study in Japan. JAR Life. March 11, 2025;14:100009.